Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.149671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Wonjun Cho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Interleukin-27, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Research Foundation of Korea, Chung-Ang University, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Interleukin-27 (IL-27) is a recently discovered cytokine that has been implicated in inflammatory and metabolic conditions, such as atherosclerosis and insulin resistance. However, the mechanisms by which IL-27 attenuates hepatic lipid accumulation in hyperlipidemic conditions and counteracts endoplasmic reticulum (ER) stress, a known risk factor for impaired hepatic lipid metabolism, have not been elucidated. This in vitro study was designed to examine the effect of IL-27 on hepatic lipid metabolism. The study included the evaluation of lipogenesis-associated proteins and ER stress markers by Western blotting, the determination of hepatic lipid accumulation by Oil Red O staining, and the examination of autophagosome formation by MDC staining. The results showed that IL-27 treatment reduced lipogenic lipid deposition and the expression of ER stress markers in cultured hepatocytes exposed to palmitate. Moreover, treatment with IL-27 suppressed CD36 expression and enhanced fatty acid oxidation in palmitate-treated hepatocytes. The effects of IL-27 on hyperlipidemic hepatocytes were attenuated when adenosine monophosphate-activated protein kinase (AMPK) or 3-methyladenine (3 MA) were inhibited by small interfering RNA (siRNA). These results suggest that IL-27 attenuates hepatic ER stress and fatty acid uptake and stimulates fatty acid oxidation via AMPK/autophagy signaling, thereby alleviating hepatic steatosis. In conclusion, this study identified IL-27 as a promising therapeutic target for nonalcoholic fatty liver disease (NAFLD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211, Giza, Egypt; Department of Medical Pharmacology, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey. Electronic address: abdel…
- Department of Pharmacy Services, Vocational School of Health Services, Bayburt University, Bayburt, 69010, Turkey.
- Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea.
- Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Electronic address: twjung@cau.ac.kr.
Förderung
- National Research Foundation of Korea
- Chung-Ang University
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Cho, W., Oh, H., Abd El-Aty, A. M., Özten, Ö., Jeong, J. H., & Jung, T. W. (2024). Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.149671
Vancouver
Cho W, Oh H, Abd El-Aty AM, Özten Ö, Jeong JH, Jung TW. Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.149671
BibTeX
@article{Cho2024,
author = {Cho, Wonjun and Oh, Heeseung and Abd El-Aty, A M and Özten, Ömer and Jeong, Ji Hoon and Jung, Tae Woo},
title = {Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.149671}
}
EUVIMED